C-YCQQFrontier Bio
tissue engineering, vascular grafts, human tissue models
replacementreplacingtissue engineered
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-YCQQ
C-YCQQC-YCQQtissue engineering, vascular grafts, human tissue models
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Eric Bennett https://www.linkedin.com/in/ericbennettsprofile/, CEO & Founder of Frontier Bio, speaks about his company's work in advancing the biofabrication of human tissues to address the global organ shortage and replace animal testing. Eric is a serial entrepreneur with expertise developing advanced technologies. Prior to Frontier Bio, he was the CTO at Aether, producing low-cost, feature-rich bioprinters. His extensive scientific background covers brain-computer interfacing, optogenetics, microfluidics, DNA assembly, in addition to bioprinting. He earned a Master’s degree in Biomedical Engineering, with his research centering on the use of optogenetics and brain-computer interfacing to study and mitigate neural disorders. Eric is committed to creating transformative technologies that push the frontier of what’s possible. Learn more about the event and 3DHEALS at https://3dheals.com/3dheals-2024-investment-outlook/ Follow us: Twitter: https://twitter.com/3dheals Instagram: http
Weekly discussion of "COVID-19, robots and us" from Silicon Valley Robotics with guests: Melonee Wise from Fetch Robotics, Eric Bennett from Frontier Bio, Tom Low from SRI International and Ken Goldberg from CITRIS CPAR and UC Berkeley, moderated by Andra Keay from Silicon Valley Robotics.
Eric Bennett | SynBioBeta Speaker Γ SynBioBeta Speaker Eric Bennett CEO Frontier Bio May 2026, SynBioBeta Speaker Eric is a serial entrepreneur and biomedical engineer. Prior to Frontier Bio, he was CTO at Aether, where he developed advanced low-cost bioprinters. His scientific background spans brain-computer interfacing, optogenetics, microfluidics, DNA assembly, and bioprinting. His past endeavors included using optogenetics and brain-computer interfaces to study and mitigate neural disorders. Eric is driven to create transformative technologies that push the frontier of what’s possible. All … Magnet Ventures Founder & Mng Partner Sushmita Sudarshan Molecular Devices Application Scientist, Assay Dev. Dawn Musil New Bloom Co-founder Nicole Richards Allonnia CEO Andrea Stephany Diaz OncoSwab CEO & Founder Connor Tsuchida Azalea Therapeutics Scientific Co-founder, VP, R&D Max Jamilly Hoxton Farms CEO & Co-founder Juliette Humer Muse Bio Founder & CEO Michael Weiner Abbratech Founder & CEO Kavya Sharman Phase Capital Managing Partner Joshua Gei
"Frontier Bio" Related News — BigGo Finance Real-time News Market Earnings Call Event Calendar Watchlist Podcast Real-time News Watchlist Market Earnings Call Event Calendar Podcast " Frontier Bio " Search Results 68 688221.SS FRONTIER BIO TECHNOLOGIES INC. Volume 1.5B ¥ 20 3.8% More related Podcast content Core Memory Podcast The Man Who Wants To Save The World From AI Plagues Rajaniemi is co of Helix Nano, an mRNA therapeutics company, and Red Queen Bio , an AI biodefense...been crossed Rajaniemi narrates a clean chronology of capability jumps that led to founding Red Que
Instagram Instagram Log In Sign Up Close Never miss a post from frontier_bio Sign up for Instagram to stay in the loop. Sign up Log in frontier_bio Verified • Follow More options frontier_bio Verified 7w Every 8 minutes, someone is added to the organ transplant waitlist. At Frontier Bio, we are developing the technology to use human stem cells to make tissue, aiming to help solve this exact crisis. 𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐥𝐢𝐯𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐧𝐞𝐱𝐭 𝐰𝐞𝐞𝐤 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐧𝐝 𝐚𝐬𝐤 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬! We will discuss: - Our tissue engineering platform and $5.5M in
Tackling the organ shortage through vascular bioengineering | Article | Drug Target Review Your browser is not supported Sorry but it looks as if your browser is out of date. To get the best experience using our site we recommend that you upgrade or switch browsers. Find a solution Skip to main content Skip to navigation Site name Site name Mast navigation Become a member Sign In Search our site Search our site Search Menu Close menu Home News Oncology AI Topics Back to parent navigation item Topics Technology Resources Diseases Drugs and therapies Research and development Tools and techniques … and poor tissue integration remain serious risks. Bennett saw an opportunity to apply biofabrication to create a better alternative. Frontier Bio is tackling one of regenerative medicine’s biggest challenges: creating living, vascularised tissues that can survive and function like native organs. Image credit: Shutterstock / Piyaset[/caption] A living graft Frontier Bio’s vascular graft combines the precision of biomaterials engineering with the adaptability of the patient’s o
Tafalgie Therapeutics | VentureRadar 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up Forgotten your password? By continuing, you agree to VentureRadar's Terms of Service , P … l health. Hera Biotech USA Privately Held Hera Biotech, Inc. was formed to apply advances in biotechnology to address unmet needs in the field of women’s health and specifically, in reproductive medicine. Hera began operations in January of 2020 as a Delaware “C” Corporation with headquarters in San Antonio, TX. Hera’s initial goal is to commercialize the MetriDx™, a novel, non-surgical method for the definitive and early diagnosis of endometriosis. AYUS BIOTECH USA Priv … iotech ; Health ; Biotechnology Show more Show less Updates All Funding Insight Grant Award Conference Competition Research 2025 BIO International Convention Conference 16 Jun 2025 One of Participating Organizations Source: convention.bio.org Show more Show less View Funding Rounds for Keywords: Biotech ; Health ; Biotechnology Export Similar Companies Similar Companies Company Country Status Description New Frontier Bio USA Privately Held New Frontier Bio is a … y... Hera Biotech USA Privately Held Hera Biotech, Inc. was formed to apply advances in biotechnology to address unmet needs in the field of women’s health and specifically, in reproductive medicine. Hera began operations in January of 2020 as a Delaware “C” Corporation with headquarters in San Antonio, TX. Hera’s initial goal is to commercialize the MetriDx™, a novel, non-surgical method for the definitive and early diagnosis of endometriosis. Hera Biotech, Inc. wa … finitive and early diagnosis of endometriosis. Hera Biotech, Inc. was formed to apply advances in biotechnology to address unmet needs in the field of women’s health and specifically, in reproductive medicine. Hera began... AYUS BIOTECH USA Privately Held AYUS BIOTECH INC. is a biotechnology start up company, focusing on advanced resear
Portfolio 投资 Immortal Dragons Investment Portfolio Purpose-driven investment portfolio supporting moonshot and radical life extension technologies. Backing technologies like wholebody replacement, 3D bioprinting, gene therapy, artificial womb technology and more. Healthspan Capital Active early stage LongBio fund https://www.healthspancapital.vc/ Frontier Bio The future of engineered tissue https://www.frontierbio.com/ Unlimited Bio Accelerate clinical trials https://www.unlimited.bio/ R3 Bio Stealth mode biotech Immune Bridge A new generation of allogeneic cell therapies to make cancer cures
#doinggoodbetter #foundersfirst | better ventures LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , an … phase of translational development, bringing its technology closer to clinical application. A glimpse into the future of medicine—where engineered tissues could restore function and transform patient care. Kattayoun (Kathy) Kordy, M.D. Tobias Lam #Biotech #RegenerativeMedicine #TissueEngineering #StartupFunding #HealthTech #Innovation 19 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Jenny Chen 1mo Report this post 🫀💶 @Cellbricks Therapeutics … the Frontier Bio team for pushing tissue engineering from theory to real-world application. Eric Bennett | Sam Pashneh-Tala Which is why we were proud to support them on their fundraising journey. 17 1 Comment Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Femovate 9,519 followers 2mo Report this post Femovate Wins #15: iSono launches point-of-care breast ultrasound system iSono Health 's ATUSA received U.S. Food and Drug Administration (FDA) 5
Visiting Frontier Bio: Bioprinting Human Tissues | Swati Chaturvedi posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree t … Report this post Thrilled to share our newest publication on Small, a follow-up application of our developed biomaterials (dSIS-NB, 10.1002/adfm.202401952, PEGNB_T, 10.1021/acsmacrolett.1c00056) from Lin Research Group at Purdue University, Weldon School of Biomedical Engineering! Honored to work with my Team under the leadership of Dr. Chien-Chi Lin on this exciting advance in human-relevant intestinal tissue engineering for disease modeling and drug testing. Paper link: htt
Frontier Bio’s Bioprinted Breakthrough: Lab-Grown Lung Tissue - 3DPrint.com | Additive Manufacturing Business Site Sponsor: Log In | Register Data & Research PRO Content Advertise Instant 3D Printing Quote Search --> Site Sponsor: News View All News Data & Analysis --> Bioprinting, Medical and Dental 3D Software 3D Scanning Aerospace Education Metals Materials Editorials/Opinions Exclusive Interviews Podcast The Hidden Cost of Lost Engineering Intent Creality 3D Successfully Listed in Hong Kong: Debuts as the First 3D Printing Company on HKEX Wells Fargo Backs ICON in Landmark Milestone for 3D … mark Milestone for 3D Printed Housing About / Team Advertise Newsletter Contact/Submit Search Data & Research PRO Content Advertise Instant 3D Printing Quote Log In Register Frontier Bio’s Bioprinted Breakthrough: Lab-Grown Lung Tissue October 1, 2024 by Vanesa Listek 3D Printing Bioprinting Exclusive Interviews Medical 3D Printing North America Share this Article --> California biotech company Frontier Bio has successfully bioprinted human lung tissue, setting a new mileston
Which Crowdfunding Platforms Grew the Fastest in 2025? Kingscrowd Newsletter Join Kingscrowd Join Kingscrowd Track Your Portfolio Become a Member Resources Resources Podcasts Charts and Analysis Login Subscribe Home Posts Which Crowdfunding Platforms Grew the Fastest in 2025? Which Crowdfunding Platforms Grew the Fastest in 2025? Platform growth in 2025 was driven by a mix of breakout deals and returning momentum. Mar 24, 2026 Happy Tuesday. Which crowdfunding platforms grew the fastest in 2025? Today we break down the data to see where capital is flowing. Plus, a deep dive into Frontier Bio, … THE FULL REPORT Have a suggestion for a data story you’d like us to look into? Submit by replying to this email. EVENTS Investment Crowdfunding Week returns April 13–15 with Tim Draper opening the conversation on the future of private markets, investor fireside sessions on alternative assets, the creator economy, and deal evaluation, plus 20 Kingscrowd-vetted companies pitching live — register free and vote to crown the $5,000 grand prize winner. REGISTER NOW KINGSCROWD PODC
Member Spotlight: Interview with CEO of Frontier Bio Eric Bennett - Healthspan Action Home About About Us Leadership Quotes & Comments Policy HSAC Internship Why Join HSAC The Coaltion View the Coalition HSAC Updates Hawaii Healthspan Corridor News & Video Newsletters News Podcasts Intern Articles Video Events Upcoming Events Past Conference List Resources Boost Your Healthspan Consumer Smart Guide Contact Donate Now Member Spotlight: Interview with CEO of Frontier Bio Eric Bennett by admin | Jul 30, 2025 | news articles By Eve Herold – Healthspan Compass Editor in Chief –
Instagram Instagram Log In Sign Up Close Never miss a post from synbiobeta Sign up for Instagram to stay in the loop. Sign up Log in synbiobeta • Follow More options synbiobeta 23w What if we could eliminate organ transplant waitlists forever? Eric Bennett and his team at Frontier Bio are pioneering exactly that—revolutionizing regenerative medicine through advanced bioprinting and stem cell self-assembly. Their innovative lung, vascular, and neural tissue models are setting new benchmarks in healthcare innovation. Bennett will be sharing how Frontier Bio is turning this vision into reality as
Frontier Bio's 3D printed blood vessels could replace animal testing News Research Directory Newsletter Partner with us Menu News Industrial Aerospace AM Space Defense Automotive AM Consumer Products Construction Sustainability Medical AM Medical Implants Medical Models Medical Devices Dental AM Bioprinting AM Market AM Hardware AM Materials AM Service AM Software Events AM Industry Acquisitions Careers Distribution Money & Funding Research & Education Analysis Resources AM Focus eBooks VoxelMatters Reviews Webinars Case Studies Executive Interviews AM Stocks VM Guides AM Focus Ca
🎧 NEW PODCAST EPISODE! It was after an email exchange with Nobel Prize winning scientist Dr Katalin Karikó, that Dr. Anushi (Kulasiri) Rajapaksa had a lightning moment and decided to back her… | MTPConnect LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time … ort this post 🎧 NEW PODCAST EPISODE! It was after an email exchange with Nobel Prize winning scientist Dr Katalin Karikó , that Dr. Anushi (Kulasiri) Rajapaksa had a lightning moment and decided to back her research innovation – founding Melbourne-based startup Misti to develop a ‘smart inhaler’ based on acoustofluidics. It’s engineered to deliver a wide range of biomolecules—including mRNA, antibodies, small molecules, and antigens. It’s a first-in-class solution for both c … That conversation was an e-mail to a leading scientist who hadn't won the Nobel Prize at the time called Kathleen Carico. We all know she's the pioneer of M RNA vaccines. And I probably said on that e-mail for too long to be honest and wrote an e-mail saying this is what we've been working on. And, you know, this discovery could be transformative to the field. Do you think there's there's value commercially in progressing? I think she responded within two hours, being on the
Revolutionary lab-grown lung tissue set to transform therapies for respiratory diseases and organ transplantation - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Tr … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Revolutionary lab-grown lung tissue set to transform therapies for respiratory diseases and organ transplantation October 2, 2024 | 1 min read Twitter LinkedIn Facebook Email Print Frontier Bio Corporation today announced a groundbreaking achievement in lab-grown lung tissue. By combining 3D bioprinting w … velopment of lab-grown tissues. Supported by a National Science Foundation SBIR grant and in collaboration with Mayo Clinic, Frontier Bio has pioneered work in blood vessels, neural tissue, and lung tissue. The company's mission is to revolutionize disease treatment and organ replacement through cutting-edge tissue engineering. For more information, visit www.frontierbio.com . ************************************************************* Image caption: Frontier Bio’s lab-grow … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
--> Frontier Bio | Engineered Tissues and Vascular Grafts top of page Home Tech Team News Menu Close CONTACT THE FUTURE OF ENGINEERED TISSUE "Frontier Bio is paving the way for a future where organ donors are no longer needed, and animal testing is a thing of the past." George Church Scientific Advisor TOWARDS ON-DEMAND HUMAN TISSUES Only 10% of Global Organ Demand is Met According to the World Health Organization >150,000 Organ Transplants Every Year Lifetime costs for an organ transplant can exceed $1M STARTING AT THE FOUNDATION: BLOOD VESSELS Engineering a new organ is impossib
Frontier Bio Stock | Buy or Sell Shares | MicroVentures Login Sign Up Frontier Bio Corporation Biotechnology Frontier Bio Stock Frontier Bio is an innovative biotechnology firm specializing in the development of engineered human tissues aimed at eliminating the need for animal testing. They focus on creating sustainable solutions for pharmaceutical testing and the potential future of organ donation. Their cutting-edge bioprinting technology supports research in areas such as lungs, brains, and vascular tissues, significantly advancing the field of tissue engineering. Founded: 2018 Frontier Bio
--> Samand Pashneh-Tala Medical Technology 3D Printing AI in Healthcare Assistive Technology Digital Health Digital Modeling Laboratory Automation Nanotechnology in Healthcare Precision Medicine Robotic Surgery Synthetic Biology Health Antibiotic Resistance Big Pharma Cancer Diabetes Heart Disease Mental Health Musculoskeletal System Respiratory Disease Stroke Augmentation Artificial Organs Biohacking Brain Interface Exoskeleton Nootropics Prostheses Vision Life Extension Aging Research Anti-Aging Biological Age Calorie Restriction Cryonics Ethics Fountains of Youth Gene Therapy Immortal Anima … ng technologies for respiratory applications. He earned his PhD and completed a fellowship at the University of Sheffield, where his research centered on developing tissue-engineered blood vessels for both clinical and in vitro uses. His expertise is further complemented by collaborations with leading medical device and 3D printing companies. Before joining Frontier Bio, Sam ran a specialized consultancy firm focused on tissue engineering and advanced medical device design, w
Sam Pashneh-Tala Email Address & Phone Number | Chief Technology Officer Of Frontier Bio | Adapt.io Why Adapt? Platform Prospecting Adapt API Enrichment Useful Links Our Data Case Studies Data OS Solutions Personas Sales Marketing Use cases Email Finder Hyper-Personalization Lead Scoring & Routing Pricing Resources Blogs Build Your Marketing Stack Case Studies Partner Program About Us Sign In Request Demo Start Free Trial Why Adapt? Platform Prospecting Get access to fresh, accurate B2B data Adapt API Find leads directly from your browser Enrichment Empower your systems with Adapt'
Frontier Bio: Providing Animal Testing Alternatives And Supplying Tissues/Organs For People Needing Transplants In A $1+ Billion Market VC PE M&A Asset Management Law Firms Profiles Contact × Search Pulse 2.0 Frontier Bio: Providing Animal Testing Alternatives And Supplying Tissues/Organs For People Needing Transplants In A $1+ Billion Market By Amit Chowdhry • Feb 12, 2024 Frontier Bio: Providing Animal Testing Alternatives And Supplying Tissues/Organs For People Needing Transplants In A $1+ Billion Market Frontier Bio creates engineered tissues to replace animal testing and save l … eing a small company, I wear many hats and also have significant involvement in grant writing, business development, and marketing.” Core Products What are the company’s core products and features? Pashneh-Tala explained: “Frontier Bio is focused on delivering tissue engineering technologies to provide alternatives to animal testing and to provide tissues/organs for people requiring transplants. Our core areas of interest are lung, neuronal, and vascular tissues. We hav … el technology and vascularized neurospheres.” “We also received an SBIR phase 1 grant from the National Science Foundation to develop our tissue-engineered blood vessel technology. In this project, we worked with Mayo Clinic to develop a tissue-engineered aneurysm model for use in medical device testing. The work was completed in 2022, and we have subsequently submitted our phase 2 proposal to continue the development of the technology.” “This year, we also achieved a signifi
Frontier Bio Leads Medical Innovation with "Lab-Grown" Blood Vessel Technology for Replacing Animal Testing - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Jo … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay Frontier Bio Leads Medical Innovation with “Lab-Grown” Blood Vessel Technology for Replacing Animal Testing October 24, 2023 | 3 min read Twitter LinkedIn Facebook Email Print Frontier Bio Corporation has unveiled a transformative method designed to fabricate living human blood vessels, setting the stage for … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
FRONTIER BIO CORPORATION - National Science Foundation Skip to main navigation Skip to search Skip to main content National Science Foundation About Explore the Map Link opens in a new tab Search content at National Science Foundation About Awards Organizations Principal Investigators FRONTIER BIO CORPORATION CA Congressional District n. 14 of CA Phone 3522786063 Postal address Show on map 3515 BREAKWATER AVE 945453610 HAYWARD United States Overview Fingerprint Awards (1) Principal Investigators (1) Organization profile Current Congressional District District n. 14 of California Congres … Congressional District District n. 14 of California Congressional Districts at Award District n. 14 of California United States California Fingerprint Dive into the research topics where FRONTIER BIO CORPORATION is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint. Epileptic Seizure Medicine and Dentistry 100% Severe Myoclonic Epilepsy of Infancy Medicine and Dentistry 100% Dravet Syndrome Neuroscience … similar technologies. For all open access content, the relevant licensing terms apply We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies National Science Foundation data protection policy Link opens in a new tab About web accessibility Link opens in a new tab Report vulnerability Link opens in a new tab Contact us
--> News | Frontier Bio top of page Home Tech Team News Menu Close CONTACT NEWS How Frontier Bio Plans to End the Organ Shortage Apr 17, 2026 | Causeartist Start Now Frontier Bio Wins Grand Prize in Investment Crowdfunding Week 2026 Apr 16, 2026 | LinkedIn Start Now Frontier Bio Wins 'Best Paper' at 50th Annual VESS Meeting for Revolutionary Single-Surgery Regenerative Vascular Graft Mar 31, 2026 | Frontier Bio Start Now The Frontier of 3D Biofabrication in the Race for Healthy Longevity Jan 19, 2026 | Pharma Phorum Start Now Frontier Bio: Redefining the Future of Regenerative Medicine … an 2, 2025 | 3D Heals Start Now Frontier Bio Nominated for 3D Printing Industry Award Nov 11, 2024 | Republic Start Now Frontier Bio’s lab-grown lung tissue – a new way for future transplants and respiratory treatments Oct 1, 2024 | 3D Printing Industry Start Now Revolutionary lab-grown lung tissue set to transform therapies for respiratory diseases and organ transplantation Oct 1, 2024 | PR Newswire Start Now Lab-grown lung tissue paves way for advances in organ transplants
Interview with Eric Bennett: Frontier Bio - 3DHeals Blog All Blogs Guides Expert’s Corner Influencer Interviews Events Courses Directory Podcast More FAQ Career Networking ? Live Facebook Group Meetup Media Store About Pitch3D Login Register Blog Events Courses Directory Podcast More All Blogs Guides Expert’s Corner Influencer Interviews FAQ Career Networking Media Store About Pitch3D ? Live Facebook Group Meetup Home Blog Influencer Interviews Interview with Eric Bennett: Frontier Bio Interview with Eric Bennett: Frontier Bio Category: Blog , Influencer Interviews Jenny Chen, M.D. … rancisco, I was delighted to learn I’d be working in the same building as Nobel Prize winner Shinya Yamanaka. His discovery of induced pluripotent stem cells (iPSCs) has revolutionized regenerative medicine and laid the groundwork for advancements in regenerative medicine. Later, Jennifer Doudna, another Nobel laureate, also established her lab at Gladstone. Her groundbreaking work on CRISPR gene-editing has transformed the possibilities of biotechnology and continues to insp
All Eric Bennett (Founder and CEO of Frontier Bio) articles | Drug Target Review Your browser is not supported Sorry but it looks as if your browser is out of date. To get the best experience using our site we recommend that you upgrade or switch browsers. Find a solution Skip to main content Skip to navigation Site name Site name Mast navigation Become a member Sign In Search our site Search our site Search Menu Close menu Home News Oncology AI Topics Back to parent navigation item Topics Technology Resources Diseases Drugs and therapies Research and development Tools and techniques Business
Interview: Eric Bennett | Frontier Bio Infinite Frontiers Home About Conversations Newsletter Sign in Subscribe Conversations Engineering Human Tissues From Scratch With Frontier Bio’s Eric Bennett Eric Bennett is the founder and CEO of Frontier Bio, a tissue engineering company developing lab-grown human tissues and organs for medical applications. 26 Sep 2025 — 5 min read Eric Bennett is the founder and CEO of Frontier Bio , a tissue engineering company developing lab-grown human tissues and organs for medical applications. What is Frontier Bio? Frontier Bio is a tissue engineeri … sibly become real. I thought creating living human tissue would be the ultimate application of 3-D printing. 3-D bioprinters were hundreds of thousands of dollars back then, so I founded a company called Aether where we made low-cost 3-D bioprinters to democratize access to bioprinting. Eventually that company wound down, and I started Frontier Bio to focus on building the tissues themselves. It’s more fun creating the actual tissues rather than the hardware that creates them
--> Team | Frontier Bio top of page Home Tech Team News Menu Close CONTACT Meet Our Team Our team of visionary entrepreneurs, scientists, and engineers works relentlessly at the frontier of science, continuously pushing the limits of what's possible. Leadership Team Eric is a serial entrepreneur and biomedical engineer. Prior to Frontier Bio, he was CTO at Aether, where he developed advanced low-cost bioprinters. His scientific background spans brain-computer interfacing, optogenetics, microfluidics, DNA assembly, and bioprinting. His past endeavors included using optogenetics and brain-co … gies that push the frontier of what’s possible. Sam completed his PhD and fellowship at the University of Sheffield. His research focused on producing tissue-engineered blood vessels for clinical and in vitro applications, including collaborations with leading medical device and 3D printing companies. Prior to joining Frontier Bio, Sam ran a boutique consultancy firm for tissue engineering and advanced medical device design, working with industry and academic clients. E … Engineer in Vascular Grafts and Biomaterial Platforms Sam completed his PhD and fellowship at the University of Sheffield. His research focused on producing tissue-engineered blood vessels for clinical and in vitro applications, including collaborations with leading medical device and 3D printing companies. Prior to joining Frontier Bio, Sam ran a boutique consultancy firm for tissue engineering and advanced medical device design, working with industry and academic clients. A